Yield10 Bioscience (YTEN.US): The 2024 Q1 financial report achieved revenue of 300,000 US dollars, previous value of 60,000 US dollars, expected value of 1.87 million US dollars; earnings per share were -4.77 US dollars, previous value was -18.16 US dollars, and expected value was -2.64 US dollars.
Yield10 Bioscience(YTEN.US)：2024年Q1财报实现营收30万美元，前值为6万美元，预期值为187万美元；每股收益为-4.77美元，前值为-18.16美元，预期值为-2.64美元。
Yield10 Bioscience (YTEN.US): The 2024 Q1 financial report achieved revenue of 300,000 US dollars, previous value of 60,000 US dollars, expected value of 1.87 million US dollars; earnings per share were -4.77 US dollars, previous value was -18.16 US dolla
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.